VDAC1 and Alzheimer disease: Conversely, as reported above, in the post-mortem brain of AD patients, VDAC1 and/or VDAC2 levels are significantly reduced or elevated in different brain regions [112], and VDAC1 is overexpressed in the hippocampus of an amyloidogenic transgenic mouse model [113,114].